Synthetic Biologics, Inc Press Releases

SYN 
$2.49
*  
0.01
 negative 
0.4%
Get SYN Alerts
*Delayed - data as of Apr. 16, 2014 
Exchange: AMEX
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By

Synthetic Biologics Appoints Mark Pimentel, M.D., Chairman of New Irritable Bowel Syndrome Clinical Advisory Board
4/14/2014 7:00:00 AM - PR Newswire

Synthetic Biologics Reports Year End 2013 Financial Results and Operational Update
3/31/2014 7:00:00 AM - PR Newswire

Synthetic Biologics to Report Year End 2013 Financial Results
3/25/2014 11:17:00 AM - PR Newswire

Top Gainers Technical Data -- Research on First Solar, Oncothyreon, Unilife, and Synthetic Biologics
3/20/2014 8:07:00 AM - PR Newswire

Synthetic Biologics Announces Issuance of U.S. Patent Adding Another Layer of Protection for the Use of Oral Estriol Candidate, Trimesta™, for Multiple Sclerosis
3/10/2014 7:00:00 AM - PR Newswire

Synthetic Biologics to Present at the 26th Annual ROTH Conference
3/5/2014 7:00:00 AM - PR Newswire

Synthetic Biologics' Board of Directors Accepts Resignation of Long-Standing Founder and Board Member
2/26/2014 5:01:00 PM - PR Newswire

Synthetic Biologics, Inc. States that Its Policy is Not to Comment on Unusual Market Activity
2/13/2014 3:57:00 PM - PR Newswire

Synthetic Biologics Announces Rhonda Voskuhl, M.D., to Present Trimesta™ Phase II Multiple Sclerosis Clinical Trial Results at the 2014 AAN Annual Meeting
2/10/2014 7:00:00 AM - PR Newswire

Synthetic Biologics to Present at the 2014 BIO CEO & Investor Conference
2/4/2014 7:00:00 AM - PR Newswire

Synthetic Biologics Strengthens Clinical & Regulatory Team to Support Expanding Pipeline of Infectious Disease Programs
1/27/2014 7:00:00 AM - PR Newswire